Skip to content
Search

Latest Stories

PSNC chief Simon Dukes steps down; community pharmacy shocked and sorry to see him go

Simon Dukes has announced that he will be resigning his post as chief executive of the Pharmaceutical Services Negotiating Committee at the end of September.

In a statement this afternoon (July 20), PSNC said it has already been looking for a new CEO to "lead the organisation from October 2021" after Dukes decided to step down.


Dukes, who joined PSNC in 2018 from counter-fraud organisation Cifas, said: "Deciding to step down was never going to be easy, but I do believe now is opportune."

Sector shocked and sorry to see Dukes go

Often described as by pharmacy insiders as "a breath of fresh air" when he joined PSNC to replace Sue Sharpe who led the organisation for 16 years, Dukes' resignation has shocked the community pharmacy sector.

"This is a very sad news," said Bharat Shah, founder of Sigma Pharmaceuticals, giving his reaction. He added that it was going to be a huge loss for community pharmacy, particularly at this very ‘critical time’.

"Simon has done so much for community pharmacy in the last few years and just recently got an agreement from DHSC to compensate contractors for the extra costs they incurred during the pandemic."

"Sorry to see him go," said Graham Phillips, award-wining community pharmacist and owner of Manor Pharmacy.

"He was a real breath of fresh air and was starting to make a difference not least the fundamental reform of PSNC and a credible relationship with government and the NHS."

Malcolm Harrison, CEO of Company Chemists' Association, said Dukes' departure would leave the PSNC with some very big shoes to fill.

“Simon has achieved much during his three years at the helm of PSNC and shown a real commitment to community pharmacy. I and everyone at the CCA wish him all the very best for the future."

PSNC’s appointments panel has already met to begin a recruitment process for the critical role which comes at a time of change for both PSNC and the LPCs as the new CEO will have to oversee an intense period of negotiations for the sector.

"We will shortly be commencing a rigorous selection programme to find Simon’s replacement," PSNC chair Sue Killen, said.

Dukes has steered PSNC and community pharmacy through a critical period, including leading negotiations that led to the agreement of the five-year national contract CPCF as well as driving the organisation's work to support contractors through the Covid-19 pandemic.

According to a statement, Dukes will remain in post until the end of September and continue to head up PSNC’s negotiating team, leading its work to agree the arrangements for Year 3 of the five-year CPCF deal.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less